Article Text

Download PDFPDF
CASE REPORT
Reactive arthritis induced by intravesical BCG therapy for bladder cancer
  1. Kaouther Ben Abdelghani,
  2. Alia Fazaa,
  3. Leila Souabni,
  4. Leith Zakraoui
  1. Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
  1. Correspondence to Dr Kaouther Ben Abdelghani, kawther_ba{at}yahoo.fr

Summary

Cancers of the bladder could be treated with intravesical instillation of BCG therapy. This treatment could lead to some complications. Osteoarticular ones are relatively uncommon. We describe an original observation, illustrating the development of reactive arthritis after intravesical BCG therapy. A 60-year-old man was followed for a T1G3 transitional papillary carcinoma of the bladder and was treated with intravesical BCG immunotherapy. Within the sixth intravesical instillation, he presented with polyarthritis confirmed by musculoskeletal ultrasound. The erythrocyte sedimentation rate was 100 mm without leukocytosis. The viral and bacterial serologies and immunological tests were negative. The ophthalmological examination revealed left conjunctivitis. Treatment with non-steroidal anti-inflammatory drugs was started, combined with the discontinuation of the intravesical instillation. No recurrence has been reported with a current decline of 2 years.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.